1 month LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks
Eli Lilly stock gains as the FDA removes tirzepatide drugs from the drug shortage list following a thorough reevaluation.
XEli Lilly stock gains as the FDA removes tirzepatide drugs from the drug shortage list following a thorough reevaluation.
X